Form 4: Structure Therapeutics Director, Sharon Tetlow, Acquires 37,500 Share Options

Director Sharon Tetlow acquired 37,500 share options in Structure Therapeutics Inc. on June 25, 2024.

Summary

• On June 25, 2024, Sharon Tetlow, a director of Structure Therapeutics Inc., acquired 37,500 share options.
• The exercise price of these options is $13.32 per share, based on the fair market value on the grant date.
• The options vest in equal monthly installments over 12 months following the grant date.
• The options expire on June 24, 2034.
• The ordinary shares of the issuer may be represented by American Depositary Shares (ADSs), with each ADS representing three ordinary shares.

Sentiment

Score: 5

Explanation: This is a neutral event, simply reporting the acquisition of share options by a director. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders, allowing investors to monitor their investment.

Stakeholder Impact

• The acquisition of share options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates